Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifaximin for Collagenous Colitis (XiCoCo)
NCT03658993Phase 3Unknown
- Start
- Nov 2018
- Primary completion
- Nov 2020
01
Overview
A Phase 3 trial of rifaximin in collagenous colitis (CC). Status: unknown.
02
Drugs
rifaximin
03
Conditions
collagenous colitis (CC)
Beyond the preview
Go deeper on NCT03658993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03658993.